ArticleRenal failure2025
Can peritoneal dialysis be continued, as opposed to switching to HD, in end-stage renal disease patients with acute coronary syndrome with pulmonary edema?
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManaging acute coronary syndrome (ACS) with pulmonary edema is challenging in end-stage kidney disease (ESKD) patients on dialysis. While hemodialysis (HD) is often chosen for rapid fluid removal, peritoneal dialysis (PD) may better preserve hemodynamic stability in patients prone to circulatory compromise. This study evaluated whether continuing PD in patients who develop ACS and pulmonary edema while already on PD is feasible for improving oxygenation and fluid management without switching to HD.
methodsThis retrospective single-center study reviewed 13 PD patients who experienced 15 ACS episodes complicated by pulmonary edema. Data collected included demographics, comorbidities, Killip classification, PD regimen modifications, and outcomes. Adjustments to PD prescriptions and their effectiveness were assessed.
resultsAmong the 15 episodes, 11 (73.3%) were successfully managed with PD alone, while 4 (26.7%) required temporary HD due to insufficient fluid removal. Most cases were Killip Class II (20%) or III (73.3%). The average ICU stay was 4 days, and in-hospital mortality was 20%.
conclusionsContinuation of PD in patients who develop ACS accompanied by pulmonary edema appears feasible in most cases, provided that PD prescriptions are carefully individualized. Switching to HD is not invariably required, but thoughtful patient selection and close monitoring remain essential to optimize clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.